|

Etrumadenant Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: AB928

Pipeline

Phase 2: 2

Top Sponsors

  • David Oh1
  • Catherine Spina1

Indications

  • Cancer2
  • Localized Prostate Cancer1
  • Oligometastatic Prostate Cancer1
  • Prostate Adenocarcinoma1
  • Prostate Cancer1

San Francisco, California1 trial

Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy

University of California, San Francisco

Phase 2

New York, New York1 trial

Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer

Columbia University Irving Medical Center / NewYork-Presbyterian Hospital

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.